
Sangre Azul was first to introduce and clinically implement innovative technologies of invisible orthodontic treatment by its chief doctor - MUDr. Andrej Thurzo PhD, MPH, MHA. Sangre Azul was also first to introduce and successfully treat 500 and later achieve over finished Invisalign treatments as only clinical practice in Slovakia. Invisalign later became a common orthodontic treatment. Sangre Azul has record of more than 300 cases on lingual braces and was first to implement acceleration technologies to treatment as Acceledent or Orthopulse which significantly reduce treatment time. Sangre…
Built from contact records that share this company: name, job title, job level, job function and person location.
Turn cold outreach into meaningful business conversations.
Rated and recommended by professionals who expect more
Annual Revenue$10M to $25M
Estimated OwnershipPrivateMatching runs on fields we already have: industry, employee range, HQ location, ownership type, funding rounds, specialities. Results come live from the ReachStream directory.